January 15, 2022 / Regnan Global Equity Impact Solutions Fund
The Q4 Impact report features a summary of the forthcoming thematic on Liquid Biopsy – a promising alternative to traditional tissue-based biopsies. The team’s stock case studies take a look at diagnostics business, Qiagen and mechanical and plant engineering firm Duerr. Read our latest thematic report below.